Page last updated: 2024-10-30

mebendazole and Growth Disorders

mebendazole has been researched along with Growth Disorders in 1 studies

Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.

Growth Disorders: Deviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. Included here are both acceleration and retardation of growth.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Stoltzfus, RJ1
Kvalsvig, JD1
Chwaya, HM1
Montresor, A1
Albonico, M1
Tielsch, JM1
Savioli, L1
Pollitt, E1

Trials

1 trial available for mebendazole and Growth Disorders

ArticleYear
Effects of iron supplementation and anthelmintic treatment on motor and language development of preschool children in Zanzibar: double blind, placebo controlled study.
    BMJ (Clinical research ed.), 2001, Dec-15, Volume: 323, Issue:7326

    Topics: Anemia, Iron-Deficiency; Anthelmintics; Anthropometry; Child, Preschool; Developmental Disabilities;

2001